Skip to product information
1 of 2

International Myeloma Foundation

IMF Publication - Understanding Revlimid® (lenalidomide)

IMF Publication - Understanding Revlimid® (lenalidomide)

Regular price $0.00 USD
Regular price Sale price $0.00 USD
Sale Sold out
Shipping calculated at checkout.

Revlimid® (lenalidomide) is an immunomodulatory drug that inhibits new blood vessel development on which cancer cells depend for sustenance and growth. Revlimid is the first oral medication that was developed for treatment of myeloma, and is used in the newly diagnosed and relapsed and/or refractory settings. You can also download a copy here:

View full details
  • Shipping Information

    FREE SHIPPING for all tip cards and publications.

    Shipping times typically take 7-14 business days. Orders totaling up to $49.99 will incur a shipping cost of $5; orders totaling $50 and up will incur a shipping cost of $10.

    Currently, the IMF does not provide international shipping via our Shopify store. If you are planning to purchase IMF merchandise or to order free educational publications outside of the U.S. (including U.S. territories), please contact the IMF directly at the or 1-818-487-7455.